Abstract
Two hundred and thirty-two patients with tubo-ovarian abscesses (TOAs) were evaluated. Ruptured TOAs were documented in seven (3%) of the patients. One hundred and seventy-five patients with TOAs were treated with antibiotics alone; for 15 of these patients, TOAs were confirmed by laparoscopy. The remaining 57 patients required surgical intervention: drainage (five patients), unilateral salpingo-oophorectomy (19) and total abdominal hysterectomy and bilateral salpingo-oophorectomy (33). A unilateral TOA was present in 163 patients (70%). Seventy-six patients with TOAs used intrauterine contraceptive devices, and in this group, 54 (71%) patients had unilateral TOAs. The most common microorganisms that were recovered from these TOAs were Escherichia coli, Bacteroides fragilis, Bacteroides species, Peptostreptococcus, Peptococcus, and aerobic streptococci. Sixty-eight percent of the patients treated with an antimicrobial regimen that included clindamycin had a decrease in the size of the TOA, while only 36.5% of those receiving antimicrobial regimens without clindamycin had a decrease in the size of the TOA (P less than .01). Long-term follow-up information (two to 10 years) was available for 58 of the patients treated with antibiotics alone. Eighteen (31%) required subsequent surgery; 12 had persistent TOAs; and six, chronic salpingo-oophoritis. Intrauterine pregnancy was documented in eight (13.8%) patients. Of the 19 patients treated with unilateral adnexectomy, two ultimately required hysterectomy and contralateral adnexectomy, while three patients in this group subsequently became pregnant (one ectopic and two intrauterine).
Original language | English (US) |
---|---|
Pages (from-to) | 876-884 |
Number of pages | 9 |
Journal | Reviews of infectious diseases |
Volume | 5 |
Issue number | 5 |
DOIs | |
State | Published - 1983 |
Bibliographical note
Funding Information:Received for publication January 19, 1983. Informed consent was obtained from the patients, and the guidelines for human experimentation of the u.s. Department of Health and Human Services and those of the University of California, San Francisco, California, were followed in the conduct of the clinical research. This work was supported in part by grant no. AI 11136from the National Institute of Allergy and Infectious Diseases. Please address requests for reprints to Dr. Richard L. Sweet, Department of Obstetrics and Gynecology, Room 6J2, San Francisco General Hospital, 1001 Potrero Avenue, San Francisco, California 94110.
Copyright:
This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine